Related Experiment Video
Updated: Sep 23, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
CL Case Conference: The Evaluation and Management of Anxiety and Cannabis Use in Pregnancy
Aditi Kappagantu1, Neeta Shenai2, Priya Gopalan3
1Department of Psychiatry, University of Illinois College of Medicine, Chicago, IL, USA.
Abstract:
We present a case of a 25-year-old G2P0010 female in her second trimester with a history of unspecified anxiety disorder, cannabis use, and insulin-dependent diabetes who was admitted to the obstetrics and psychiatry hospitals multiple times over the span of months for self-induced vomiting. During her hospitalization, the patient was trialed on different anxiolytics with varied safety profiles in pregnancy. Reproductive psychiatry experts discuss critical aspects of psychiatric care during pregnancy, including medication management of anxiety and agitation while weighing the risks of medicine versus the risks of untreated illness. The impact of perinatal cannabis use on anxiety, its effect on treatment planning, and other pertinent systemic factors to consider in treating complex psychiatric patients in obstetrical settings, such as disposition, are also reviewed.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Asthma-IV: Nursing Management
First, in...
Anxiolytic Drugs: Benzodiazepines and Buspirone
